NIKI · Niki BioSolutions, Inc. · Executive Compensation
Market Cap
$6.49M
Shares
3.12M
Volume · Oct 20
21.81K
Avg daily vol (3M)
159.12K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Thomas Freeburg | Chief Financial Officer | Appointed | 2026-10-13 |
| Ian Huen | Chairman of the Board of Directors | Appointed | 2026-09-04 |
| Alidad Mireskandari | President and Chief Operating Officer | Appointed | 2026-09-04 |
| Ian Huen | Chief Executive Officer | Appointed | 2026-09-04 |
| Douglas Arner | Independent Director | Appointed | 2026-07-20 |
| Laura A. Philips | Independent Director | Appointed | 2026-07-20 |
| Justin Wu | Independent Director | Appointed | 2026-07-20 |
| Kira Sheinerman | Director | Appointed | 2026-07-20 |
| Ian Huen | Chairman | Appointed | 2026-07-20 |
Leadership
- Ian Huen CEO, Chairman
- Thomas Freeburg CFO
- Alidad Mireskandari COO
- Douglas Arner Board Member
- Justin Wu Board Member
- Kira Sheinerman Board Member
- Laura A. Philips Board Member